 |
Interview with Maria Freese, Director of Government Relations and Policy, National Committee to Preserve Social Security and Medicare. She discusses HR 6331 which is still unsettled. After the the July Fourth holiday, congress will have about a week to fix the dispute. At issue is preventing the proposed physician fee cuts by cutting Medicare payments to private insurance companies in the Medicare Advantage Program. The insurance industry is fighting the cuts, and the bill is hung up in the Senate. Emeritus News |
From:
lhuston10
Views:
1
 0
ratings |
| Time: 07:15 | More in News & Politics |
Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator
Medicare News, Syndicated
Comments Off
Mar 212011
Health affairs, Vol. 24, No. 1. (2005), pp. 42-51.
The implantable cardioverter defibrillator (ICD) is a costly new treatment for patients at high risk of sudden cardiac death. Randomized trials of the ICD showed it to be effective in some groups of patients but not in others. While new trials testing the ICD were ongoing to clarify the evidence, policymakers faced immediate decisions about providing insurance coverage for the device. The high cost of ICDs, the large population of patients potentially eligible to receive them, the potential to reduce preventable deaths, and the unsettled state of the medical evidence provided a challenge to evidence-based medicine and to policymakers.
MA Hlatky, GD Sanders, DK Owens
The implantable cardioverter defibrillator (ICD) is a costly new treatment for patients at high risk of sudden cardiac death. Randomized trials of the ICD showed it to be effective in some groups of patients but not in others. While new trials testing the ICD were ongoing to clarify the evidence, policymakers faced immediate decisions about providing insurance coverage for the device. The high cost of ICDs, the large population of patients potentially eligible to receive them, the potential to reduce preventable deaths, and the unsettled state of the medical evidence provided a challenge to evidence-based medicine and to policymakers.
MA Hlatky, GD Sanders, DK Owens
Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator.
Medicaid News, Syndicated
Comments Off
Mar 212011
Health affairs, Vol. 24, No. 1. (Jan 2005), pp. 42-51.
The implantable cardioverter defibrillator (ICD) is a costly new treatment for patients at high risk of sudden cardiac death. Randomized trials of the ICD showed it to be effective in some groups of patients but not in others. While new trials testing the ICD were ongoing to clarify the evidence, policymakers faced immediate decisions about providing insurance coverage for the device. The high cost of ICDs, the large population of patients potentially eligible to receive them, the potential to reduce preventable deaths, and the unsettled state of the medical evidence provided a challenge to evidence-based medicine and to policymakers.
MA Hlatky, GD Sanders, DK Owens
The implantable cardioverter defibrillator (ICD) is a costly new treatment for patients at high risk of sudden cardiac death. Randomized trials of the ICD showed it to be effective in some groups of patients but not in others. While new trials testing the ICD were ongoing to clarify the evidence, policymakers faced immediate decisions about providing insurance coverage for the device. The high cost of ICDs, the large population of patients potentially eligible to receive them, the potential to reduce preventable deaths, and the unsettled state of the medical evidence provided a challenge to evidence-based medicine and to policymakers.
MA Hlatky, GD Sanders, DK Owens
Medigap supplemental coverage can be too pricey for younger Medicare beneficiaries
Medicare News, Syndicated
Comments Off
Mar 082011
One night three years ago, Joe Hobson finished reading a book, went to sleep and woke up blind. The problem, caused by a rare hereditary disease, forced him to give up his 20-year communications job, along with its generous health insurance. Now 63, the Arlington man is covered by Medicare, the f...
Free Medicare counseling for seniors
Medicare News, Syndicated
Comments Off
Dec 132010
The Medicare Open Enrollment period ends Dec. 31. Any senior citizens who received a letter from Humana, Anthem, Secure Horizons or MVP - advising that their medical insurance is ending - can get local help in enrolling with a new plan.
Recent Comments